Jun 4 2012
Dabigatran (Pradaxa) seems to get a lot of negative press in the US; the lawyers are circling! Here is a recent article from the European Medicine Agency reporting that Dabigatran post-market data show less bleeding fatalities than in the clinical trials.
Comments (0)Anticoagulant Therapy
No comments here.